117 related articles for article (PubMed ID: 3653210)
41. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
[TBL] [Abstract][Full Text] [Related]
42. Circulating levels of prolactin in breast cancer patients.
Mujagić Z; Mujagić H; Prnjavorac B
Med Arh; 2005; 59(1):33-5. PubMed ID: 15822682
[TBL] [Abstract][Full Text] [Related]
43. Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.
Lissoni P; Malugani F; Casu M; Bukovec R; Egardi R; Bordin V; Fumagalli E; Mengo S; Gardani G
Neuro Endocrinol Lett; 2002 Feb; 23(1):61-3. PubMed ID: 11880864
[TBL] [Abstract][Full Text] [Related]
44. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
45. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.
De Hert M; Peuskens J; Sabbe T; Mitchell AJ; Stubbs B; Neven P; Wildiers H; Detraux J
Acta Psychiatr Scand; 2016 Jan; 133(1):5-22. PubMed ID: 26114737
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of estrogen and prolactin receptor analysis in human breast cancer.
Waseda N; Kato Y; Imura H; Kurata M
Jpn J Cancer Res; 1985 Jun; 76(6):517-23. PubMed ID: 2991064
[TBL] [Abstract][Full Text] [Related]
47. Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab.
Caponnetto S; Iannantuono GM; Barchiesi G; Magri V; Gelibter A; Cortesi E
Oncology; 2017; 93(1):62-66. PubMed ID: 28407622
[TBL] [Abstract][Full Text] [Related]
48. Different responses in little and bigbig prolactin to metoclopramide in subjects with hyperprolactinemia due to 150-170 kD (bigbig) prolactin.
Bjøro T; Johansen E; Frey HH; Turter A; Torjesen PA
Acta Endocrinol (Copenh); 1993 Apr; 128(4):308-12. PubMed ID: 8498149
[TBL] [Abstract][Full Text] [Related]
49. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
[TBL] [Abstract][Full Text] [Related]
50. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia.
Paraiba DB; Soares CR; Bartolini P; Arthuso FS; Borba EF; Bonfa E; Bronstein MD
Clin Exp Rheumatol; 2010; 28(6):866-72. PubMed ID: 21205462
[TBL] [Abstract][Full Text] [Related]
51. [Evaluation of functional periodicity of the pituitary gland by harmonic analysis.--IV) Circadian prolactin secretion in women with breast cancer].
Zauli C; Murialdo G; Piscopo R; Santoni O; Calzia R; Giovale M
Boll Soc Ital Biol Sper; 1983 Apr; 59(4):462-8. PubMed ID: 6882541
[TBL] [Abstract][Full Text] [Related]
52. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
53. Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth.
Liby K; Neltner B; Mohamet L; Menchen L; Ben-Jonathan N
Breast Cancer Res Treat; 2003 May; 79(2):241-52. PubMed ID: 12825859
[TBL] [Abstract][Full Text] [Related]
54. Altered diurnal rhythm of prolactin in systemic sclerosis.
Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
[TBL] [Abstract][Full Text] [Related]
55. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.
Cavaco B; Prazeres S; Santos MA; Sobrinho LG; Leite V
J Endocrinol Invest; 1999 Mar; 22(3):203-8. PubMed ID: 10219888
[TBL] [Abstract][Full Text] [Related]
56. Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.
Secreto G; Recchione C; Cavalleri A; Miraglia M; Dati V
Br J Cancer; 1983 Feb; 47(2):269-75. PubMed ID: 6824571
[TBL] [Abstract][Full Text] [Related]
57. Prolactin may be increased in newly diagnosed celiac children and adolescents and decreases after 6 months of gluten-free diet.
Delvecchio M; Faienza MF; Lonero A; Rutigliano V; Francavilla R; Cavallo L
Horm Res Paediatr; 2014; 81(5):309-13. PubMed ID: 24603159
[TBL] [Abstract][Full Text] [Related]
58. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
Barbarino A; De Marinis L; Anile C; Menini E; Merlini G; Maira G
Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636
[TBL] [Abstract][Full Text] [Related]
59. Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia.
Sekiya K; Karashima T; Ikuyama S; Muta K; Kato K; Ibayashi H
Endocrinol Jpn; 1985 Apr; 32(2):207-14. PubMed ID: 4042986
[TBL] [Abstract][Full Text] [Related]
60. Stage-dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors.
Bartsch C; Bartsch H; Fuchs U; Lippert TH; Bellmann O; Gupta D
Cancer; 1989 Jul; 64(2):426-33. PubMed ID: 2736489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
